Stinging insect allergy: current perspectives on venom immunotherapy.

Area of Science:

• Allergy and Immunology
• Public Health

Background:

• Systemic allergic reactions to insect stings impact up to 5% of the population.
• Severe reactions, though rare, can cause significant anxiety and impair quality of life.
• Fear of future reactions significantly affects patient well-being.

Purpose of the Study:

• To evaluate the effectiveness and cost-effectiveness of venom immunotherapy (VIT).
• To assess the impact of VIT on reducing systemic reactions and improving quality of life.
• To inform treatment decisions for insect sting allergies.

Main Methods:

• Systematic review of existing literature on venom immunotherapy.
• Health economic analysis of VIT for preventing future systemic reactions.
• Assessment of quality of life improvements associated with VIT.

Main Results:

• Venom immunotherapy (VIT) significantly reduces the risk of future systemic reactions (SRs).
• VIT also decreases the incidence of large local reactions and enhances disease-specific quality of life.
• VIT is generally not cost-effective for preventing SRs unless individuals are frequently stung or quality of life improvements are prioritized.

Conclusions:

• For most patients with insect sting allergy, anxiety and quality of life concerns should guide treatment decisions.
• A patient-centered approach is crucial for managing insect sting allergy.
• Future research should focus on improving VIT safety, convenience (e.g., sublingual immunotherapy), and understanding its effects in pediatric populations.